References
- Moroz A, Felisbino SL, Deffune E. Platelet and plasma bioactive scaffolds for stem cell differentiation: What are we missing? Platelets 2013;[Epub ahead of print]. doi:10.3109/09537104.2013.836748
- Anitua E, Prado R, Orive G. Endogenous morphogens and fibrin bioscaffolds for stem cell therapeutics. Trends Biotechnol 2013;31:364–374
- Anitua E, Sanchez M, Prado R, Orive G. The P makes the difference in plasma rich in growth factors (PRGF) technology. Platelets 2011;22:473–474
- Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002;115:3861–3863
- Schick PK, Wojensk CM, Bennett V, Denisova L. Fibronectin isoforms in megakaryocytes. Stem Cells 1996;14:212–219
- Mosher DF. Plasma fibronectin concentration: A risk factor for arterial thrombosis? Arterioscler Thromb Vasc Biol 2006;26:1193–1195
- Anitua E, Prado R, Azkargorta M, Rodriguez-Suarez E, Iloro I, Casado-Vela J, Elortza F, Orive G. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome. J Tissue Eng Regen Med 2013;[Epub ahead of print]. doi:10.1002/term.1721
- Mccafferty MH, Lepow M, Saba TM, Cho E, Meuwissen H, White J, Zuckerbrod SF. Normal fibronectin levels as a function of age in the pediatric population. Pediatr Res 1983;17:482–485
- Anitua E, Muruzabal F, Pino A, Merayo-Lloves J, Orive G. Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea 2013;32:1380–1386
- Moroz A, Bittencourt RA, Almeida RP, Felisbino SL, Deffune E. Platelet lysate 3D scaffold supports mesenchymal stem cell chondrogenesis: An improved approach in cartilage tissue engineering. Platelets 2013;24:219–225
- Anitua E, Prado R, Orive G. Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology. Ther Deliv 2013;4:1163–1177
- Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007;47:1436–1446
- Walenda G, Hemeda H, Schneider RK, Merkel R, Hoffmann B, Wagner W. Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells. Tissue Eng Part C Methods 2012;18:924–934
- Pawitan JA. Platelet rich plasma in xeno-free stem cell culture: The impact of platelet count and processing method. Curr Stem Cell Res Ther 2012;7:329–335
- Anitua E, Sanchez M, Prado R, Orive G. The type of platelet-rich plasma may influence the safety of the approach. Knee Surg Sports Traumatol Arthrosc 2012;[Epub ahead of print]. doi:10.1007/s00167-012-2043-1
- Ramanathan A, Karuri N. Fibronectin alters the rate of formation and structure of the fibrin matrix. Biochem Biophys Res Commun 2013;[Epub ahead of print]. doi: 10.1016/j.bbrc.2013.11.090
- Ho W, Tawil B, Dunn JC, Wu BM. The behavior of human mesenchymal stem cells in 3D fibrin clots: Dependence on fibrinogen concentration and clot structure. Tissue Eng 2006;12:1587–1595
- Singh P, Schwarzbauer JE. Fibronectin and stem cell differentiation – Lessons from chondrogenesis. J Cell Sci 2012;125:3703–3712